A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

NCT05192395 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DWJ1525
DRUG: DWP16001
DRUG: DWC202101

Sponsor

Daewoong Pharmaceutical Co. LTD.